← Back to patent-cliff list
Tolfenamic Acid
Tier C — Watch / tradeTolfenamic Acid
-
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：COXs
Brand：Clotam, Migea
Indications (approved)：Arthritis, Migraine, Pain, Dysmenorrhoea
Regional status
US
No progress
2021-01-01
EU
Approved
2000-06-06
China
Approved
2005-07-13
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tolfenamic Acid?
Approved indications include: Arthritis, Migraine, Pain, Dysmenorrhoea.
When does the Tolfenamic Acid patent expire?
No public expiry year is available for Tolfenamic Acid yet; this page updates once verified.
How do I get a quote for Tolfenamic Acid intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27